Research and Development

The Research and Development team at Eidos Therapeutics is responsible for advancing the scientific discovery and clinical development of AG10, a targeted therapy for transthyretin amyloidosis. Comprising experts in various scientific and clinical fields, the team conducts rigorous research, designs and executes preclinical and clinical trials, and collaborates closely with regulatory bodies to ensure the safe and effective progression of the therapeutic from concept to market. Their work is essential in fulfilling the company’s mission to improve the lives of patients affected by this condition.